AMGN compared with VCEL: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

VCELVericel Corp

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

VCELVericel Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

468.57▼−2.07%

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

VCELVericel Corp

50.79▲+11.68%

Regular sessionNov 5 '26

Mkt cap$2.3BRevenue$85MQ3 FY26Revenue$276MFY25

Compare

Regular sessionNov 5 '26

AMGNAmgen Inc

VCELVericel Corp

468.57▼−2.07%

Price

50.79▲+11.68%

$258.8B

Mkt cap

$2.3B

Q3 FY26$10.4B

Revenue

$85MQ3 FY26

FY25$36.8B

Revenue

$276MFY25

AMGN468.57▼−2.07%vsVCEL50.79▲+11.68%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

VCEL: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only VCEL 5

—Matricel GmbHunlistedsupplier

—MediWoundunlistedsupplier

—AllCare Plus Pharmacyunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Orsini Pharmaceutical Services

unlistedsupplier

1 more · VCEL chain ›

Price

rebased to 0%

AMGN, solidVCEL, dashed